News - Page 197 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Nova Mentis Upgrades U.S. Listing to the OTCQB Venture Market

Nova Mentis Upgrades U.S. Listing to the OTCQB Venture Market

Post published:March 10, 2021
Post category:Press Release

Read more about the article DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a Study as First Clinical Trial in Opioid Use Disorder in the UK

DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a Study as First Clinical Trial in Opioid Use Disorder in the UK

Post published:March 10, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Post published:March 10, 2021
Post category:Press Release

Read more about the article MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m)

MindMed Increases Cash on Hand to CAD $205.2m (USD $162m), Closes Financing of CAD $19.5m (USD $15.4m)

Post published:March 9, 2021
Post category:Press Release

Read more about the article Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition

Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition

Post published:March 9, 2021
Post category:Press Release

Read more about the article Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Optimi Health Accelerates Psilocybin Clinical Trial Program with IMPACT

Post published:March 9, 2021
Post category:Press Release

Read more about the article Red Light Holland’s Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global Comedy Superstar Russell Peters, Accepted to Steam, the Largest Digital Distribution Platform for PC Gaming

Red Light Holland’s Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global Comedy Superstar Russell Peters, Accepted to Steam, the Largest Digital Distribution Platform for PC Gaming

Post published:March 9, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

Post published:March 9, 2021
Post category:Press Release

Numinus to expand state-of-the-art psychedelics research laboratory

Post published:March 9, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020

COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020

Post published:March 9, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.